Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Andrew Perlman, Executive Vice President of Tularik, talks to The Wall Street Transcript.


Business Editors

NEW YORK--(BUSINESS WIRE)--Jan. 8, 2001

The Wall Street Transcript A generic term for any kind of copy, particularly an official or certified representation of the record of what took place in a court during a trial or other legal proceeding.

A transcript of record
 has published an in-depth interview with Andrew Perlman, Executive Vice President of Tularik (Nasdaq:TLRK), in which he talks at length about the company's future.

The entire 2,300-word interview is available free online at http://www.twst.com/ceos.htm

Perlman gives an overview of the company. "It was late in 1991 that Dave Goeddel got together with his colleagues Bob Tjian and Steve McKnight to discuss starting a company around the notion that one could alter gene regulation to the benefit of people with diseases. That concept has stood the test of time and forms the basis of our mission statement: to build a pharmaceutical company to discover novel and important small-molecule therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 that work by virtue of their ability to regulate genes."

Perlman explains, "One of the exciting aspects of our gene regulation platform is that it is very broad, a platform that can address almost any type of human disease. Some diseases are characterized char·ac·ter·ize  
tr.v. character·ized, character·iz·ing, character·iz·es
1. To describe the qualities or peculiarities of: characterized the warden as ruthless.

2.
 by genes which are underexpressed and others by an overexpression of genes. Our approach is to discover drugs that increase the expression of beneficial genes or decrease the expression of harmful genes."

Perlman asserts, "We have a validated val·i·date  
tr.v. val·i·dat·ed, val·i·dat·ing, val·i·dates
1. To declare or make legally valid.

2. To mark with an indication of official sanction.

3.
 scientific approach to the discovery of drugs. Our pipeline in important therapeutic areas addresses unmet un·met  
adj.
Not satisfied or fulfilled: unmet demands. 
 medical needs with huge market potential. And very importantly, we have managed to maintain product rights in all of our product areas."

This interview is part of a 319-page JP Morgan Morgan, American family of financiers and philanthropists.

Junius Spencer Morgan, 1813–90, b. West Springfield, Mass., prospered at investment banking.
 H&Q Healthcare Conference Issue available at http://www.twst.com/info/info251.htm or by calling 212/952-7433

The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors Long-term investor

A person who makes investments for a period of at least five years in order to finance his or her long-term goals.
 for over 38 years.

The Wall Street Transcript has launched a new free service where investors can ask Tularik (or any public company) a question at http://www.qawire.com

Serious investors may now receive free email alerts containing links to TWST articles whenever TWST publishes an interview on the companies they follow by using the new Alerts.com service available at http://www.twst.com/alerts.html.

The Wall Street Transcript does not endorse To sign a paper or document, thereby making it possible for the rights represented therein to pass to another individual. Also spelled indorse.


endorse (indorse) v.
 the views of any interviewees nor does it make stock recommendations. For subscription information call 800/246-7673.

http://www.twst.com

http:// www.tularik.com
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 8, 2001
Words:388
Previous Article:Apogee Announces Major Design Win - Direct Digital Amplification --DDX-- Technology Helps Altec Lansing Pack Superior Sound into Micro-Speaker...
Next Article:Packard BioScience's CEO Emery Olcott talks to The Wall Street Transcript.



Related Articles
The Wall Street Transcript Publishes CEO Interview With Andrew Sealfon of Repro-Med Systems in Biotechnology Industry Issue.
Tularik to Present At Thomas Weisel Partners Healthcare Tailwinds Conference 2001.
Tularik to Present At Salomon Smith Barney Health Care Conference 2001.
Tularik to Present at Credit Suisse First Boston Health Care Conference.
Tularik Announces Departure of Andrew J. Perlman, EVP.
Tularik Strengthens Management Team with Appointment of Andrew J. Perlman, M.D., Ph.D.; Perlman to Present at the Salomon Smith Barney 2002 Health...
Tularik Announces Departure of CFO Corinne H. Lyle.
AMGEN, TULARIK ENTER INTO DEAL RIGHTS GAINED FOR CANCER DRUGS.
Tularik to Present at the Wachovia Securities Equity Conference.
Tularik to Present at the UBS Global Life Sciences Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles